Liquid Biopsy in Cancer Patients -

Liquid Biopsy in Cancer Patients

The Hand Lens for Tumor Evolution
Buch | Softcover
XI, 214 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2017
Springer International Publishing (Verlag)
978-3-319-85719-0 (ISBN)
48,14 inkl. MwSt
Jetzt zum Sonderpreis
Listenpreis (bisher): 90,94 €
This text is designed to provide readers with a useful and comprehensive resource and state-of-the-art overview about the new, growing and fast-expanding field of "liquid biopsy" for the management of cancer patients. The liquid biopsy represents an important turning point in oncology since it provides a tool for a serial monitoring of disease. Liquid biopsy is our "hand lens" to follow molecular changes that characterize tumor development and progression. The book provide a unique and valuable resource on the clinical relevance of liquid biopsy as well as on the technical aspects of liquid biopsy analysis. All invited authors are recognized experts in their field. 
Liquid Biopsy in Cancer Patients: The Hand Lens for Tumor Evolution is targeted to resident and fellows physicians, medical oncologists, molecular biologists and biotechnologists.

Antonio Giordano, MD, PhD Director Sbarro Institute for Cancer Research and Molecular Medicine and Center of Biotechnology College of Science and TechnologyTemple University BioLife Science Bldg. Suite 431 1900 N 12th Street Philadelphia PA 19122 UsaTel: +1 215-204 9520 Fax: +1 215-204 9522 E-mail: giordano@temple.edupresident@shro.org Antonio Russo, MD, PhD Professor of Medical Oncology Section of Medical Oncology Department of Surgical and Oncological Sciences School of Medicine, University of Palermo, Via del Vespro 129 - 90127 Palermo (Italy) Adjunct Full Professor in Temple University, Institute for Cancer Research and Molecular Medicine and Center of Biotechnology - College of Science and Biotechnology, Philadelphia (USA) Phone: + 39-091-6552500; Fax: +39-091-6554529 E-mail: antonio.russo@usa.net Christian Rolfo, MD, PhDHead of Unit Phase I - Early Clinical TrialsDirector of Clinical Trial Management Program Oncology DepartmentUniversity Hospital AntwerpUZA, Wilrijkstraat 10, 2650 EdegemTel +32 3 821 3646E-mail: christian.rolfo@uza.be

Introduction.- Precision Medicine: Are We There?.- Clonal Cancer Evolution and Intra-tumor Heterogeneity.- Tissue vs. Liquid Biopsy: Opposite or Complementary?.- Technical Aspects for the Evaluation of Circulating Tumor Cells (CTCs).- Technical Aspects for the Evaluation of Circulating Nucleic Acids (CNA): Circulating Tumor DNA (ctDNA) and Circulating MicroRNAs.- Technical Aspects for the Evaluation of Exosome and their Content.- Liquid Biopsy in Breast Cancer.- Liquid Biopsy in Head and Neck Cancers.- Liquid Biopsy in NSCLC.- Liquid Biopsy in Gastric Cancer.- Liquid Biopsy in Pancreatic Cancer.- Liquid Biopsy in HCC.- Liquid Biopsy in CRC.- Liquid Biopsy in GIST.- Liquid Biopsy in Kidney Cancer.- Liquid Biopsy in Melanoma.

Erscheint lt. Verlag 3.8.2018
Reihe/Serie Current Clinical Pathology
Zusatzinfo XI, 214 p. 41 illus., 40 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 178 x 254 mm
Gewicht 601 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 2. Studienabschnitt (Klinik) Pathologie
Schlagworte Circulating Nucleic Acids (CNA) • circulating tumor DNA (ctDNA) • Exosome • Liquid biopsy in breast cancer • Liquid biopsy in GIST • Liquid biopsy in melanoma • Liquid biopsy in NSCLC
ISBN-10 3-319-85719-3 / 3319857193
ISBN-13 978-3-319-85719-0 / 9783319857190
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Thomas Kirchner; Hans Konrad Müller-Hermelink …

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
42,00
Klinisch-pathologische Übersichtskarten

von Thomas Cerny; Kirill Karlin

Buch | Hardcover (2023)
Springer (Verlag)
34,99